Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection

Micro-Abstract In a cohort of 84 patients treated with stereotactic body radiation therapy (SBRT) for early-stage lung cancer, we compared the toxicity rates of those undergoing SBRT with and without previous anatomic lung resection. We identified a trend toward increased grade 2+ pulmonary toxicity...

Full description

Saved in:
Bibliographic Details
Published inClinical lung cancer Vol. 16; no. 5; pp. 379 - 384
Main Authors Hayes, Jason T, David, Elizabeth A, Qi, LiHong, Chen, Allen M, Daly, Megan E
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2015
Subjects
Aged
Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - surgery
Female
Follow-Up Studies
Hematology, Oncology and Palliative Medicine
Humans
Incidence
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Lung resection
Male
Neoplasm Staging
Non–small-cell lung cancer
Pulmonary/Respiratory
Radiation pneumonitis
Radiation Pneumonitis - epidemiology
Radiation Pneumonitis - etiology
Radiosurgery - adverse effects
Radiosurgery - methods
Retrospective Studies
SBRT
Survival Rate
Toxicity
Non–small-cell lung cancer
Lung resection
Toxicity
SBRT
Radiation pneumonitis
Online AccessGet full text

Cover

More Information
Summary:Micro-Abstract In a cohort of 84 patients treated with stereotactic body radiation therapy (SBRT) for early-stage lung cancer, we compared the toxicity rates of those undergoing SBRT with and without previous anatomic lung resection. We identified a trend toward increased grade 2+ pulmonary toxicity with previous surgery. However, the toxicity rates were low in both groups, suggesting SBRT is safe after lung resection.
ISSN:1525-7304
1938-0690
DOI:10.1016/j.cllc.2015.01.006